Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 -- -- Interim systemic lung cancer data with Olvi-Vec demonstrated partial responses in ...
Mike Francisco was an athletic 35-year-old Phoenix medical professional when he was diagnosed with late-stage colon cancer. His story is not unusual.
Nutrition is increasingly recognized as a modifiable factor influencing the risk, progression, and survivorship of cancers that disproportionately affect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results